Pharmaceutical Industry
Nova Science Publishers Inc (Verlag)
978-1-61209-394-9 (ISBN)
As the scope of available drug therapies expands, spending on prescription drugs has become the fastest-growing category of total spending on health care in the United States. Recently, that growth has slowed and that slowdown reflects changes in both the supply and demand for prescription drugs. This book examines the innovation, development and complexity issues present in the pharmaceutical industry.
Preface; Authorized Generic Pharmaceuticals: Effects on Innovation; Authorized Generics: An Interim Report; Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, Hearing on "Pay-for-Delay Settlements, Authorized Generics, & Follow-On Biologies: Thoughts on the How Competition Law Can Best Protect Consumer Welfare in the Pharmaceutical Context"; Federal R&D, Drug Discovery, & Pricing: Insights from the NIH-University-Industry Relationship; Pharmaceutical R&D & the Evolving Market for Prescription Drugs; Federal Taxation of the Drug Industry & Its Effects on New Drug Development; Pharmaceutical Patent Litigation Settlements: Implications for Competition & Innovation; FDA's Authority to Regulate Drug Compounding: A Legal Analysis; Promotional Spending for Prescription Drugs; Index.
| Zusatzinfo | Illustrations |
|---|---|
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 260 x 180 mm |
| Gewicht | 524 g |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Technik | |
| Wirtschaft ► Betriebswirtschaft / Management | |
| ISBN-10 | 1-61209-394-9 / 1612093949 |
| ISBN-13 | 978-1-61209-394-9 / 9781612093949 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
